PRINCETON, N.J., Dec. 19, 2011 /PRNewswire/ -- Next Inning
Technology Research (http://www.nextinning.com), an online
investment newsletter focused on semiconductor and technology
stocks, has published updated outlooks for Qualcomm (Nasdaq: QCOM),
Research in Motion (Nasdaq: RIMM), Lam Research (Nasdaq: LRCX),
Novellus Systems (Nasdaq: NVLS), and Acme Packet (Nasdaq:
APKT).
Next Inning editor Paul
McWilliams has leveraged a decades-long career as a
semiconductor industry insider to deliver in-depth insights and
winning stock selections for his newsletter
subscribers.
After careful research, Next Inning published a special report
last month outlining the rolling impact from shortages of hard-disk
drives. A number of the predictions McWilliams shared in
this report were confirmed by Intel when it lowered its
guidance. In this report, McWilliams examines how
companies in the hard-disk drive (HDD), solid-state disk drive
(SSD), NAND Flash, PC, microprocessor and other semiconductor
sectors will be affected. For tech investors, this is a
must-read report.
Trial subscribers will receive McWilliams' earnings previews and
his highly acclaimed State of Tech reports that offer in-depth,
sector-by-sector coverage of over 65 leading tech companies and
specific guidance on which stocks he thinks investors should own
and which should be avoided. These reports, as well as
McWilliams' regular commentary and real-time trade alerts, are
available for free to trial subscribers.
To take advantage of this offer and receive these reports for
free, please visit the following link:
https://www.nextinning.com/subscribe/index.php?refer=prn1330
McWilliams covers these topics and more in his recent
reports:
- During its conference call, RIM executives stated their
BlackBerry 10 would be delayed until midyear because they are
waiting for a specific, but unnamed chipset to become
available. This is clearly disappointing for RIM investors,
but what about investors in the chipset company? Are there
reasons to think the chipset is from Qualcomm and, if so, will it
be late with its new Snapdragon chips or is RIM's schedule simply
in line with Qualcomm's last stated commitment? Does
McWilliams think the new chips due out next year from Qualcomm will
be something special? Why? What does McWilliams think
about RIM as an investment?
- Is the recently announced merger of Lam Research and Novellus
Systems a winner for investors of both companies? What is so
innovative about how this deal was constructed? How will arbitrage
trading by big investors impact the stock prices of these two
companies prior to the deal closing? What will come into play
right after closing and likely boost the price of Lam shares?
- Acme Packet is now down roughly 50% from August when McWilliams
advised Next Inning subscribers that the stock was significantly
overvalued. Is the stock now trading at a bargain price? What
strategy can investors leverage with Acme Packet that could produce
a 40% to 60% 13-month return and present lower risk than just
owning the stock outright?
Founded in September 2002, Next
Inning's model portfolio has returned 244% since its inception
versus 34% for the S&P 500.
About Next Inning:
Next Inning is a subscription-based investment newsletter that
provides regular coverage on more than 150 technology and
semiconductor stocks. Subscribers receive intra-day analysis,
commentary and recommendations, as well as access to monthly
semiconductor sales analysis, regular Special Reports, and the Next
Inning model portfolio. Editor Paul
McWilliams is a 30+ year semiconductor industry veteran.
NOTE: This release was published by Indie Research Advisors,
LLC, a registered investment advisor with CRD #131926.
Interested parties may visit adviserinfo.sec.gov for additional
information. Past performance does not guarantee future
results. Investors should always research companies and securities
before making any investments. Nothing herein should be construed
as an offer or solicitation to buy or sell any security.
CONTACT: Marcia Martin, Next
Inning Technology Research, +1-888-278-5515 SOURCE: Indie Research
Advisors, LLC
SOURCE Indie Research Advisors, LLC